• Experience Imagio

Experience IMAGIO®

Introducing Opto-Acoustic Ultrasound (OA/US) and the Imagio® Breast Imaging System

Learn more about the novel combination of state-of-the-art ultrasound and opto-acoustic (sometimes referred to as photoacoustic) technology

New hybrid modality reveals the telltale signs of cancer with a painless, non-invasive scan to help diagnose breast cancer and reduce unnecessary biopsies.

Nationwide Demo Tour

Imagio® OA/US Roadshow Scans Across America

Get a live demo at your facility as the Imagio® OA/US Roadshow crosses the country. Click here for latest updates and request a stop.

Introducing the Imagio® Breast Imaging System from Seno Medical

Pioneered by Seno Medical, Opto-Acoustic/Ultrasound (OA/US) shines a new light on breast cancer diagnostics, enabling a real-time assessment to differentiate malignant from benign breast tissue.

FDA approval of Imagio® Breast Imaging System offers breast centers a unique opportunity to enhance the patient experience by reducing biopsies of benign masses.

Without dyes, radiation, or invasive procedures, Imagio® provides the clinician an immediate, objective diagnosis leveraging the AI-driven clinical decision support tool, SenoGram®.

Virtual Demo

See Imagio® and SenoGram® in action with a clinical demonstration of OA/US technology and examples of images that can differentiate malignant and benign breast tissue on screen and in color, with the painless, real-time OA/US scan.

Newest version of Imagio® Breast Imaging System receives FDA approval and ready for delivery